These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 28383050

  • 1. The global regulator Ncb2 escapes from the core promoter and impacts transcription in response to drug stress in Candida albicans.
    Shariq M, Dhamgaye S, Nair R, Goyal N, Jain V, Mukhopadhyay A, Mondal AK, Mukhopadhyay G, Prasad R.
    Sci Rep; 2017 Apr 06; 7():46084. PubMed ID: 28383050
    [Abstract] [Full Text] [Related]

  • 2. Ncb2 is involved in activated transcription of CDR1 in azole-resistant clinical isolates of Candida albicans.
    Shukla S, Yadav V, Mukhopadhyay G, Prasad R.
    Eukaryot Cell; 2011 Oct 06; 10(10):1357-66. PubMed ID: 21856931
    [Abstract] [Full Text] [Related]

  • 3. Expression of the CDR1 efflux pump in clinical Candida albicans isolates is controlled by a negative regulatory element.
    Gaur NA, Manoharlal R, Saini P, Prasad T, Mukhopadhyay G, Hoefer M, Morschhäuser J, Prasad R.
    Biochem Biophys Res Commun; 2005 Jun 24; 332(1):206-14. PubMed ID: 15896319
    [Abstract] [Full Text] [Related]

  • 4. Transcriptional activation and increased mRNA stability contribute to overexpression of CDR1 in azole-resistant Candida albicans.
    Manoharlal R, Gaur NA, Panwar SL, Morschhäuser J, Prasad R.
    Antimicrob Agents Chemother; 2008 Apr 24; 52(4):1481-92. PubMed ID: 18268086
    [Abstract] [Full Text] [Related]

  • 5. Mediator Tail Module Is Required for Tac1-Activated CDR1 Expression and Azole Resistance in Candida albicans.
    Liu Z, Myers LC.
    Antimicrob Agents Chemother; 2017 Nov 24; 61(11):. PubMed ID: 28807920
    [Abstract] [Full Text] [Related]

  • 6. PAP1 [poly(A) polymerase 1] homozygosity and hyperadenylation are major determinants of increased mRNA stability of CDR1 in azole-resistant clinical isolates of Candida albicans.
    Manoharlal R, Gorantala J, Sharma M, Sanglard D, Prasad R.
    Microbiology (Reading); 2010 Feb 24; 156(Pt 2):313-326. PubMed ID: 19910410
    [Abstract] [Full Text] [Related]

  • 7. Molecular determinants of transient and reversible induced up-regulation of CaCDR1 in azole susceptible clinical isolates of Candida albicans.
    Manoharlal R, Sharma M, Prasad R.
    Biosci Rep; 2011 Feb 24; 31(1):31-43. PubMed ID: 20377529
    [Abstract] [Full Text] [Related]

  • 8. Candida albicans Zn Cluster Transcription Factors Tac1 and Znc1 Are Activated by Farnesol To Upregulate a Transcriptional Program Including the Multidrug Efflux Pump CDR1.
    Liu Z, Rossi JM, Myers LC.
    Antimicrob Agents Chemother; 2018 Nov 24; 62(11):. PubMed ID: 30104273
    [Abstract] [Full Text] [Related]

  • 9. Constitutive activation of the PDR16 promoter in a Candida albicans azole-resistant clinical isolate overexpressing CDR1 and CDR2.
    De Deken X, Raymond M.
    Antimicrob Agents Chemother; 2004 Jul 24; 48(7):2700-3. PubMed ID: 15215129
    [Abstract] [Full Text] [Related]

  • 10. Selected mechanisms of molecular resistance of Candida albicans to azole drugs.
    Gołąbek K, Strzelczyk JK, Owczarek A, Cuber P, Ślemp-Migiel A, Wiczkowski A.
    Acta Biochim Pol; 2015 Jul 24; 62(2):247-51. PubMed ID: 25901298
    [Abstract] [Full Text] [Related]

  • 11. Genomewide location analysis of Candida albicans Upc2p, a regulator of sterol metabolism and azole drug resistance.
    Znaidi S, Weber S, Al-Abdin OZ, Bomme P, Saidane S, Drouin S, Lemieux S, De Deken X, Robert F, Raymond M.
    Eukaryot Cell; 2008 May 24; 7(5):836-47. PubMed ID: 18390649
    [Abstract] [Full Text] [Related]

  • 12. Increased expression and hotspot mutations of the multidrug efflux transporter, CDR1 in azole-resistant Candida albicans isolates from vaginitis patients.
    Looi CY, D' Silva EC, Seow HF, Rosli R, Ng KP, Chong PP.
    FEMS Microbiol Lett; 2005 Aug 15; 249(2):283-9. PubMed ID: 16006060
    [Abstract] [Full Text] [Related]

  • 13. SRE1 and SRE2 are two specific steroid-responsive modules of Candida drug resistance gene 1 (CDR1) promoter.
    Karnani N, Gaur NA, Jha S, Puri N, Krishnamurthy S, Goswami SK, Mukhopadhyay G, Prasad R.
    Yeast; 2004 Feb 15; 21(3):219-39. PubMed ID: 14968428
    [Abstract] [Full Text] [Related]

  • 14. Beauvericin Potentiates Azole Activity via Inhibition of Multidrug Efflux, Blocks Candida albicans Morphogenesis, and Is Effluxed via Yor1 and Circuitry Controlled by Zcf29.
    Shekhar-Guturja T, Tebung WA, Mount H, Liu N, Köhler JR, Whiteway M, Cowen LE.
    Antimicrob Agents Chemother; 2016 Dec 15; 60(12):7468-7480. PubMed ID: 27736764
    [Abstract] [Full Text] [Related]

  • 15. Mutations in transcription factor Mrr2p contribute to fluconazole resistance in clinical isolates of Candida albicans.
    Wang Y, Liu JY, Shi C, Li WJ, Zhao Y, Yan L, Xiang MJ.
    Int J Antimicrob Agents; 2015 Nov 15; 46(5):552-9. PubMed ID: 26404130
    [Abstract] [Full Text] [Related]

  • 16. TAC1, transcriptional activator of CDR genes, is a new transcription factor involved in the regulation of Candida albicans ABC transporters CDR1 and CDR2.
    Coste AT, Karababa M, Ischer F, Bille J, Sanglard D.
    Eukaryot Cell; 2004 Dec 15; 3(6):1639-52. PubMed ID: 15590837
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Pdr1 regulates multidrug resistance in Candida glabrata: gene disruption and genome-wide expression studies.
    Vermitsky JP, Earhart KD, Smith WL, Homayouni R, Edlind TD, Rogers PD.
    Mol Microbiol; 2006 Aug 15; 61(3):704-22. PubMed ID: 16803598
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. RTA2, a novel gene involved in azole resistance in Candida albicans.
    Jia XM, Ma ZP, Jia Y, Gao PH, Zhang JD, Wang Y, Xu YG, Wang L, Cao YY, Cao YB, Zhang LX, Jiang YY.
    Biochem Biophys Res Commun; 2008 Sep 05; 373(4):631-6. PubMed ID: 18601908
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.